| Net Cash Provided by (Used in) Operating Activities |
$49,139,000 |
USD |
-10% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$36,028,000 |
USD |
-168% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$7,076,000 |
USD |
94% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
800,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
235,635,813 |
shares |
-1.7% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$6,035,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$39,418,000 |
USD |
-11% |
Q4 2025 |
FY 2025 |
| Operating Lease, Liability |
$10,452,000 |
USD |
-4.7% |
Q4 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$162,028,000 |
USD |
-23% |
Q4 2025 |
FY 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.0553 |
pure |
0.36% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
30,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$43,000,000 |
USD |
39% |
Q4 2025 |
FY 2025 |